Cerity Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.9M Sell
862,623
-51,068
-6% -$2.36M 0.07% 228
2025
Q1
$55.7M Buy
913,691
+10,987
+1% +$670K 0.11% 171
2024
Q4
$49.4M Buy
902,704
+11,399
+1% +$624K 0.11% 175
2024
Q3
$46.1M Buy
891,305
+249,475
+39% +$12.9M 0.1% 181
2024
Q2
$26.7M Sell
641,830
-241,589
-27% -$10M 0.07% 235
2024
Q1
$47.3M Buy
883,419
+507,727
+135% +$27.2M 0.12% 166
2023
Q4
$19.3M Buy
375,692
+54,351
+17% +$2.79M 0.06% 247
2023
Q3
$18.7M Sell
321,341
-292,888
-48% -$17M 0.09% 199
2023
Q2
$39.3M Buy
614,229
+70,722
+13% +$4.52M 0.15% 134
2023
Q1
$42.1M Buy
543,507
+70,677
+15% +$5.47M 0.1% 145
2022
Q4
$34.7M Buy
472,830
+184,763
+64% +$13.6M 0.22% 99
2022
Q3
$20.5M Sell
288,067
-3,596
-1% -$256K 0.25% 84
2022
Q2
$22.5M Buy
291,663
+45,040
+18% +$3.47M 0.25% 81
2022
Q1
$17.4M Buy
246,623
+29,495
+14% +$2.08M 0.27% 73
2021
Q4
$13.5M Buy
217,128
+21,173
+11% +$1.32M 0.21% 96
2021
Q3
$11.6M Buy
195,955
+17,766
+10% +$1.05M 0.26% 85
2021
Q2
$11.9M Sell
178,189
-156
-0.1% -$10.4K 0.26% 79
2021
Q1
$11.3M Sell
178,345
-37,814
-17% -$2.39M 0.27% 79
2020
Q4
$13.4M Buy
216,159
+48,022
+29% +$2.98M 0.43% 48
2020
Q3
$10.1M Buy
168,137
+82,981
+97% +$5M 0.42% 49
2020
Q2
$5.01M Buy
85,156
+34,792
+69% +$2.05M 0.28% 69
2020
Q1
$2.81M Sell
50,364
-5,414
-10% -$302K 0.18% 107
2019
Q4
$3.58M Buy
55,778
+10,402
+23% +$668K 0.18% 99
2019
Q3
$2.3M Sell
45,376
-844
-2% -$42.8K 0.14% 147
2019
Q2
$2.1M Sell
46,220
-4,466
-9% -$203K 0.13% 148
2019
Q1
$2.42M Sell
50,686
-1,382
-3% -$65.9K 0.16% 145
2018
Q4
$2.71M Buy
52,068
+338
+0.7% +$17.6K 0.18% 127
2018
Q3
$3.21M Buy
51,730
+3,028
+6% +$188K 0.22% 116
2018
Q2
$2.7M Buy
48,702
+680
+1% +$37.6K 0.2% 124
2018
Q1
$3.04M Sell
48,022
-6,649
-12% -$420K 0.23% 114
2017
Q4
$3.35M Buy
54,671
+2,354
+4% +$144K 0.22% 103
2017
Q3
$3.34M Sell
52,317
-114,103
-69% -$7.27M 0.24% 97
2017
Q2
$5.92M Buy
166,420
+122,290
+277% +$4.35M 0.5% 40
2017
Q1
$2.4M Buy
+44,130
New +$2.4M 0.2% 103